Latest news
NSAID use may lower AMD risk - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Wed, 05 Aug 2026 19:04:21 GMTOcular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 16:00:37 GMTOcular Therapeutix Reports Q2 2026 Results, Confirms Q4 2026 AXPAXLI NDA Submission Plan for Wet AMD - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMT